Zhanjun Dong
Impact in
- Analytical Chemistry top 10%
- Analytical Methods in Pharmaceuticals
- Analytical chemistry methods development
Papers in
- Oncology 12
- Pancreatic and Hepatic Oncology Research 4
- Drug Transport and Resistance Mechanisms 4
-
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Ying Li (14 shared papers)Yajing Li (9 shared papers)Jing An (7 shared papers)Ran Fu (5 shared papers)Yin Wu (2 shared papers)Meng Lu (5 shared papers)Dong Xiao (1 shared paper)Xiaonan Wang (4 shared papers)
- Journals
- Molecules (6 papers)Drug Design Development and Therapy (5 papers)Annals of Palliative Medicine (3 papers)Journal of Pharmaceutical and Biomedical Analysis (3 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- China
In The Last Decade
Zhanjun Dong
37 papers receiving 294 citations
Peers
Comparison fields: 5 of 70
- Analytical Chemistry 37
- Pharmacology 31
- Cancer Research 38
- Toxicology 8
- Complementary and alternative medicine 14
Countries citing papers authored by Zhanjun Dong
This map shows the geographic impact of Zhanjun Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanjun Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanjun Dong more than expected).
Fields of papers citing papers by Zhanjun Dong
This network shows the impact of papers produced by Zhanjun Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanjun Dong. The network helps show where Zhanjun Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhanjun Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 54 | |
| 2 | 2014 | 25 | |
| 3 | 2021 | 16 | |
| 4 | 2021 | 15 | |
| 5 | 2019 | 15 | |
| 6 | 2022 | 14 | |
| 7 | 2021 | 12 | |
| 8 | 2018 | 11 | |
| 9 | 2019 | 11 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 8 | |
| 13 | 2022 | 7 | |
| 14 | 2023 | 7 | |
| 15 | 2021 | 7 | |
| 16 | 2021 | 7 | |
| 17 | 2022 | 6 | |
| 18 | 2023 | 6 | |
| 19 | 2023 | 6 | |
| 20 | 2022 | 6 |
About Zhanjun Dong
Zhanjun Dong is a scholar working on Oncology, Pharmacology, Analytical Chemistry, Toxicology and Complementary and alternative medicine, having authored 40 papers that have together received 295 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Analytical chemistry methods development (3 papers), Analytical Methods in Pharmaceuticals (3 papers), Forensic Toxicology and Drug Analysis (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Analytical Chemistry (37 citations), Pharmacology (31 citations), Cancer Research (38 citations), Toxicology (8 citations) and Complementary and alternative medicine (14 citations). Zhanjun Dong has collaborated with scholars based in China. Frequent co-authors include Ying Li, Yajing Li, Jing An, Ran Fu, Yin Wu, Meng Lu, Dong Xiao, Xiaonan Wang, Guanggai Xia and Weiwei Wu. Their work appears in journals such as Molecules, Drug Design Development and Therapy, Annals of Palliative Medicine, Journal of Pharmaceutical and Biomedical Analysis and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.